Abstract
Long lasting pyrethroid treated bednets are the most important tool for preventing malaria. Pyrethroid resistant Anopheline mosquitoes are now ubiquitous in Africa though the public health impact remains unclear, impeding the deployment of more expensive nets. Meta-analyses of bioassay studies and experimental hut trials are used to characterise how pyrethroid resistance changes the efficacy of standard bednets, and those containing the synergist piperonyl butoxide (PBO), and assess its impact on malaria control. New bednets provide substantial personal protection until high levels of resistance though protection may wane faster against more resistant mosquito populations as nets age. Transmission dynamics models indicate that even low levels of resistance would increase the incidence of malaria due to reduced mosquito mortality and lower overall community protection over the life-time of the net. Switching to PBO bednets could avert up to 0.5 clinical cases per person per year in some resistance scenarios.
Article and author information
Author details
Funding
Medical Research Council
- Thomas S Churcher
Department for International Development
- Thomas S Churcher
European Research Council
- Hilary Ranson
Innovative Vector Control Consortium
- Thomas S Churcher
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Simon I Hay, Institute for Health Metrics and Evaluation, United States
Publication history
- Received: March 16, 2016
- Accepted: August 18, 2016
- Accepted Manuscript published: August 22, 2016 (version 1)
- Version of Record published: September 15, 2016 (version 2)
Copyright
© 2016, Churcher et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 3,456
- Page views
-
- 688
- Downloads
-
- 72
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.